Added to YB: 2024-07-25
Pitch date: 2024-07-24
A [bullish]
Agilent Technologies, Inc.
+33.32%
current return
Author Info
No bio for this author
Company Info
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Market Cap
$41.4B
Pitch Price
$131.67
Price Target
168.00 (-4%)
Dividend
0.69%
EV/EBITDA
20.60
P/E
28.97
EV/Sales
5.94
Sector
Life Sciences Tools and Services
Category
growth
Agilent Technologies, Inc. - $A
A: #1-2 in lab instruments/services. Strong margins, FCF. 56% recurring rev. 6-8% market growth. New CEO risk. Fair value at 31x PE. Doubled API capacity for oligonucleotides. $3.3B market opportunity. Recent BIOVECTRA acquisition adds biologics, GLP-1 capabilities. Diversified across markets/geographies. $168 PT.
Read full article (8 min)